You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GBG

Showing 1 - 25 of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Innsbruck, Linz, Salzburg

Recruiting
  • Breast Cancer
    • Innsbruck, Austria
    • +2 more
    Feb 20, 2023

    Metastatic Breast Cancer Trial in Frankfurt am Main (Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel,

    Recruiting
    • Metastatic Breast Cancer
    • Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel, vinorelbine) / Endocrine therapy (exemestane, fulvestrant, letrozole, tamoxifen)
    • Frankfurt am Main, Germany
      Agaplesion Markus Krankenhaus - Klinik für Gynäkologie und Gebur
    Feb 22, 2022

    Breast Cancer in Pregnancy Register Study

    Recruiting
    • Breast Cancer
      • Neu Isenburg, Hessen, Germany
        German Breast Group
      Feb 22, 2022

      Problem Behavior Trial in Malmö (Good Behavior Game)

      Completed
      • Problem Behavior
      • Good Behavior Game
      • Malmö, Sweden
      • +4 more
      Mar 31, 2023

      Node-positive Breast Cancer Trial in Worldwide (Tailored axillary surgery - both Arms, Radiotherapy - Arm A, Radiotherapy - Arm

      Recruiting
      • Node-positive Breast Cancer
      • Tailored axillary surgery - both Arms
      • +2 more
      • Dornbirn, Austria
      • +44 more
      Nov 22, 2021

      Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

      Recruiting
      • Breast Cancer
      • Hangzhou, Zhejiang, China
        2nd Affiliated Hospital, School of Medicine, Zhejiang University
      Jun 28, 2022

      Early-Stage Breast Carcinoma Trial in Germany, Switzerland (without preoperative access to lymphoscintigraphy findings)

      Completed
      • Early-Stage Breast Carcinoma
      • without preoperative access to lymphoscintigraphy findings
      • Essen, Nordrhein-Westfalen, Germany
      • +22 more
      Jul 8, 2020

      BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

      Completed
      • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
      • Barretos, SP, Brazil
        Barretos Cancer Hospital
      Dec 25, 2022

      ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

      Recruiting
      • Breast Cancer Female
      • +4 more
        • Ho Chi Minh City, Vietnam
        • +1 more
        Oct 16, 2023

        HER2-positive Breast Cancer Trial (Inavolisib, PHESGO, Endocrine therapy)

        Not yet recruiting
        • HER2-positive Breast Cancer
        • (no location specified)
        Mar 23, 2022

        Breast Cancer Metastatic Trial in Ravensburg (Ribociclib, Anastrozole, Letrozole)

        Active, not recruiting
        • Breast Cancer Metastatic
        • Ravensburg, Germany
          Studienzentrum Onkologie Ravensburg
        Mar 7, 2022

        HER2-negative Breast Cancer, Triple Negative Breast Cancer Trial in France, Germany, Ireland (Capecitabine, Carboplatin,

        Recruiting
        • HER2-negative Breast Cancer
        • Triple Negative Breast Cancer
        • Brasschaat, Belgium
        • +161 more
        Nov 2, 2022

        Breast Cancer Trial in Worldwide (anastrozole, )

        Completed
        • Breast Cancer
        • Newcastle, New South Wales, Australia
        • +73 more
        Oct 5, 2021

        Metastatic Breast Cancer Trial in Worldwide (metastatic lesion biopsy)

        Suspended
        • Metastatic Breast Cancer
        • metastatic lesion biopsy
        • Brussels, Belgium
        • +59 more
        Jan 17, 2023

        Well-being in Elementary School Children, Mental Health in Elementary School Children, Work-related Stress in Teachers Trial in

        Recruiting
        • Well-being in Elementary School Children
        • +3 more
        • PAX Good Behavior Game
        • +2 more
        • Stockholm, Sweden
          Several Schools in Sweden will be recruited, although as partici
        Jun 1, 2022

        Peri-implantitis Trial in Kristianstad (GBO and GBG, Standard treatment)

        Completed
        • Peri-implantitis
        • GBO and GBG
        • Standard treatment
        • Kristianstad, Sweden
          Kristianstad University, Department of Health Sciences
        Feb 22, 2019

        Triple Negative Breast Cancer Trial in Canada, United States (Placebo, Atezolizumab)

        Active, not recruiting
        • Triple Negative Breast Cancer
        • Mobile, Alabama
        • +216 more
        Jul 27, 2022

        Breast Cancer Trial in Frankfurt (Epirubicin, nab-Paclitaxel, Cyclophosphamide)

        Completed
        • Breast Cancer
        • Frankfurt, Hessen, Germany
          Klinikum Frankfurt Höchst
        Feb 1, 2021

        Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

        Not yet recruiting
        • Triple Negative Breast Cancer
        • Dhaka, Bangladesh
          Bangabandhu Sheikh Mujib Medical University
        May 24, 2023

        Mental Health Wellness 1, Mental Disorders Trial (PAX Good Behavior Game)

        Completed
        • Mental Health Wellness 1
        • Mental Disorders
        • PAX Good Behavior Game
        • (no location specified)
        Nov 1, 2018

        Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

        Not yet recruiting
        • Neuroendocrine Tumors
        • Portland, Oregon
          Providence Portland Cancer Institute - Franz Clinic
        Feb 10, 2022

        Breast Tumor Trial in China (Epirubicin plus Cyclophosphamide, Taxanes, Taxanes plus Carboplatin)

        Recruiting
        • Breast Neoplasm
        • Epirubicin plus Cyclophosphamide
        • +2 more
        • Fuding, Fujian, China
        • +26 more
        Mar 28, 2022

        Neuroendocrine Tumors Trial in Sweden (177Lu-DOTATOC, Capecitabine)

        Not yet recruiting
        • Neuroendocrine Tumors
        • Göteborg, Sweden
        • +3 more
        May 19, 2022

        Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)

        Not yet recruiting
        • Triple-negative Breast Cancer
        • Taxane and Carboplatin
        • +2 more
        • (no location specified)
        Apr 25, 2023

        Breast Cancer Trial in Frankfurt (MEDI4736 (Anti PD-L1), Placebo, nab-Paclitaxel)

        Completed
        • Breast Cancer
        • MEDI4736 (Anti PD-L1)
        • +4 more
        • Frankfurt, Hessen, Germany
          Centrum für Hämatologie und Onkologie am Bethanien-Krankenhaus
        Feb 11, 2021